IL112320A0 - Quinazoline-2,4- diones, their preparation and pharmaceutical compositions containing them - Google Patents

Quinazoline-2,4- diones, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL112320A0
IL112320A0 IL11232095A IL11232095A IL112320A0 IL 112320 A0 IL112320 A0 IL 112320A0 IL 11232095 A IL11232095 A IL 11232095A IL 11232095 A IL11232095 A IL 11232095A IL 112320 A0 IL112320 A0 IL 112320A0
Authority
IL
Israel
Prior art keywords
diones
quinazoline
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL11232095A
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL112320A0 publication Critical patent/IL112320A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11232095A 1994-01-14 1995-01-12 Quinazoline-2,4- diones, their preparation and pharmaceutical compositions containing them IL112320A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9400680A GB9400680D0 (en) 1994-01-14 1994-01-14 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
IL112320A0 true IL112320A0 (en) 1995-03-30

Family

ID=10748817

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11232095A IL112320A0 (en) 1994-01-14 1995-01-12 Quinazoline-2,4- diones, their preparation and pharmaceutical compositions containing them

Country Status (6)

Country Link
AU (1) AU1534195A (en)
GB (1) GB9400680D0 (en)
IL (1) IL112320A0 (en)
PE (1) PE43595A1 (en)
WO (1) WO1995019346A1 (en)
ZA (1) ZA95269B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW450807B (en) * 1995-09-15 2001-08-21 Pfizer Pharmaceutical compositions for treating tinnitus comprising neuroprotective agents
DK0901487T3 (en) * 1996-05-15 2003-08-25 Pfizer 2,3,6-trisubstituted 4 (3H) -quinazolinones
GB2316616A (en) * 1996-09-02 1998-03-04 Lilly Industries Ltd Modulation of GluR5 receptors in the hippocampus to treat psychiatric disorders
US6306909B1 (en) 1997-03-12 2001-10-23 Queen's University At Kingston Anti-epileptogenic agents
US6627755B1 (en) 1997-06-09 2003-09-30 Pfizer Inc Quinazolin-4-one AMPA antagonists
EP0884310B1 (en) * 1997-06-09 2005-09-07 Pfizer Products Inc. Quinazolin-4-one ampa antagonists
WO2002083651A2 (en) * 2001-04-11 2002-10-24 Queen's University At Kingston Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
TW200403066A (en) * 2002-04-30 2004-03-01 Novartis Ag New uses of substituted aminoalkanephosphonic acids
GB0416730D0 (en) * 2004-07-27 2004-09-01 Novartis Ag Organic compounds
GB0507298D0 (en) * 2005-04-11 2005-05-18 Novartis Ag Organic compounds
PT2239257E (en) * 2008-01-30 2012-09-12 Shin Poong Pharmaceutical Co Ltd Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
WO2011009951A1 (en) * 2009-07-23 2011-01-27 Novartis Ag 1h-quinazoline-2, 4 -diones for use in the treatment of neuronal ceroid lipofuscinosis
WO2011048150A1 (en) * 2009-10-20 2011-04-28 Novartis Ag Use of 1h-quinazoline-2,4-diones
EP2571865A1 (en) * 2010-05-20 2013-03-27 Novartis AG 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives
CA2800970A1 (en) * 2010-06-24 2011-12-29 Novartis Ag Use of 1h-quinazoline-2,4-diones
UA113280C2 (en) 2010-11-11 2017-01-10 AMINOSPIRT-SUBSTITUTED Derivatives of 2,3-Dihydroimimidase $ 1,2-c] QINAZOLINE, SUITABLE FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS, DISEASES AND DISEASES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068263B (en) * 1959-11-05
JP3381384B2 (en) * 1994-04-30 2003-02-24 株式会社島津製作所 Correction method for nuclear medicine imaging device

Also Published As

Publication number Publication date
WO1995019346A1 (en) 1995-07-20
AU1534195A (en) 1995-08-01
GB9400680D0 (en) 1994-03-09
PE43595A1 (en) 1996-01-08
ZA95269B (en) 1996-07-15

Similar Documents

Publication Publication Date Title
HUP9901243A3 (en) Quinazoline derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds
IL115039A (en) Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
IL120141A0 (en) Substituted quinazoline derivatives and pharmaceutical compositions containing them
HUS1400001I1 (en) Quinazoline derivatives, producing them and pharmaceutical compositions containing the compounds
IL116770A (en) 2,8-disubstituted quinazolinones their preparation and pharmaceutical compositions containing them
IL106353A0 (en) Unsymmetrical mono-3-nitro-bis-naphthalimides,their preparation and pharmaceutical compositions containing them
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
IL126638A0 (en) Substituted isoquinoline-3-carboxamides their preparation and their use as pharmaceuticals
HUP9904046A3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing the same
IL119994A0 (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones their preparation and pharmaceutical compositions containing them
HUP0004398A3 (en) Alpha-aryl-n-alkylnitrones and pharmaceutical compositions containing the same
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
IL109073A0 (en) Amidine derivatives, their preparation and pharmaceutical compositions containing them
IL112320A0 (en) Quinazoline-2,4- diones, their preparation and pharmaceutical compositions containing them
IL100364A0 (en) Benzodiazepinones,their preparation and pharmaceutical compositions containing them
HUP9802132A3 (en) Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them
HUP9801386A3 (en) Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them
IL135723A (en) 1'-Ä4-Ä1-4-Fluorophenyl)-1H-indole-3-ylÜ-1-butylÜ-spiroÄisobenzofuran-1-(3H),4'-piperidineÜhydrohal ogenides and pharmaceutical compositions containing them
IL108624A0 (en) Pseudopeptides, their preparation and pharmaceutical compositions containing them
IL114623A0 (en) Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
IL118672A0 (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
HUP9903526A3 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same